Siamak Rahman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Siamak Rahman has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Parisa Partownavid
UCLA Ronald Reagan Medical Center
5 shared publications- Mansoureh Eghbali
Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine, University of California Los Angeles, BH-550 CHS, Los Angeles, CA 90095-7115, USA
3 shared publications - Brittany Nicole Burton
UCLA David Geffen School of Medicine, Los Angeles, California
2 shared publications - Soban Umar
Department of Anesthesiology and Perioperative Medicine University of California, Los Angeles Los Angeles California USA
2 shared publications - Xuezhi Dong
Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Suite 3325, Los Angeles, CA 90095, USA; Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA
2 shared publications Abie Mendelsohn
Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California
1 shared publication
Latest Publications
- Open Access
- 20 January 2025
- Published by Wolters Kluwer Health in A&A Practice
- Vol. 19 (1) , e01906
Stellate Ganglion Blockade as Rescue Therapy for Recurrent Torsades de Pointes and as a Bridge to Surgical Sympathectomy in a Pediatric Patient: A Case Report
Management of refractory ventricular fibrillation (VF) in patients with implantable implantable cardioverter defibrillator (ICD) presents a therapeutic challenge. We present a case of pediatric refractory ventricular tachycardia (VT)/Torsade de Pointe managed effectively with bilateral stellate ganglion block (SGB) with a long-acting local anesthetic for 18 days as a bridge to more definitive surgical management.
- 20 January 2025
- Published by Wolters Kluwer Health in A&A Practice
- Vol. 19 (1) , e01906
Open AccessStellate Ganglion Blockade as Rescue Therapy for Recurrent Torsades de Pointes and as a Bridge to Surgical Sympathectomy in a Pediatric Patient: A Case Report
Management of refractory ventricular fibrillation (VF) in patients with implantable implantable cardioverter defibrillator (ICD) presents a therapeutic challenge. We present a case of pediatric refractory ventricular tachycardia (VT)/Torsade de Pointe managed effectively with bilateral stellate ganglion block (SGB) with a long-acting local anesthetic for 18 days as a bridge to more definitive surgical management.
- 1 January 2022
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 148 (1) , 82-83
Local Anesthetic Infusion for Improving Pain From Head and Neck Cancer Surgery
To the Editor With great anticipation we read the recent article titled “Postoperative Pain Treatment with Continuous Local Anesthetic Wound Infusion in Patients with Head and Neck Cancer: A Nonrandomized Clinical Trial.”1 Of primary importance, the authors should be singularly commended for pursuing treatment alternatives away from standard opioid administration. As we join a number of institutions following the example of Gostian and colleagues,1 we felt it prudent to specify details that may limit clinical application of the specific technique described to optimize future efforts. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 1 January 2022
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 148 (1) , 82-83
Local Anesthetic Infusion for Improving Pain From Head and Neck Cancer Surgery
To the Editor With great anticipation we read the recent article titled “Postoperative Pain Treatment with Continuous Local Anesthetic Wound Infusion in Patients with Head and Neck Cancer: A Nonrandomized Clinical Trial.”1 Of primary importance, the authors should be singularly commended for pursuing treatment alternatives away from standard opioid administration. As we join a number of institutions following the example of Gostian and colleagues,1 we felt it prudent to specify details that may limit clinical application of the specific technique described to optimize future efforts. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 29 March 2018
- Published by Springer Nature
- p. 637-648
Regional Anesthesia for Chronic Disease States
- 1 April 2016
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 60 (2) , 78-79
Involvement of Opioid Receptors in Lipid Rescue of Bupivacaine-Induced Cardiotoxicity
Surv Anesthesiol 2016;60(2):78–79 Lipid rescue, or lipid emulsion (LE), has been shown to resuscitate patients from cardiac-related effects of local anesthetics and from toxicities caused by a wide range of drugs, such as calcium channel blockers, β-blockers, and psychoactive agents. Using nonselective opioid receptor antagonists (ORAs) and highly selective ORAs, the authors of this study examined whether the rescue action of LE is mediated through central or peripheral opioid receptors.
- 1 April 2016
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 60 (2) , 78-79
Involvement of Opioid Receptors in Lipid Rescue of Bupivacaine-Induced Cardiotoxicity
Surv Anesthesiol 2016;60(2):78–79 Lipid rescue, or lipid emulsion (LE), has been shown to resuscitate patients from cardiac-related effects of local anesthetics and from toxicities caused by a wide range of drugs, such as calcium channel blockers, β-blockers, and psychoactive agents. Using nonselective opioid receptor antagonists (ORAs) and highly selective ORAs, the authors of this study examined whether the rescue action of LE is mediated through central or peripheral opioid receptors.
- 28 November 2011
- Published by Springer Nature
- p. 541-556
Regional Anesthesia for Chronic Disease States
- 28 November 2011
- Published by Springer Nature
- p. 541-556
Regional Anesthesia for Chronic Disease States
- 1 February 2011
- Published by Elsevier in Biophysical Journal
- Vol. 100 (3) , 296a
CVT Inhibits the Intralipid Rescue of Bupivacaine-Induced Cardiotoxicity in a Dose-Dependant Manner
- 1 February 2011
- Published by Elsevier in Biophysical Journal
- Vol. 100 (3) , 296a
CVT Inhibits the Intralipid Rescue of Bupivacaine-Induced Cardiotoxicity in a Dose-Dependant Manner
- 1 February 2011
- Published by Elsevier in Biophysical Journal
- Vol. 100 (3) , 296a
Phosphorylation of GSK-3b is Required for Intralipid to Protect the Heart Against Ischemia/Reperfusion Injury
- 1 February 2011
- Published by Elsevier in Biophysical Journal
- Vol. 100 (3) , 296a
Phosphorylation of GSK-3b is Required for Intralipid to Protect the Heart Against Ischemia/Reperfusion Injury
- 1 July 2009
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 16 (4) , 300-303
Deep Vein Thrombosis Prophylaxis: Friend or Foe
This article reviews certain aspects of venous thromboembolism, a major cause of morbidity and mortality among hospitalized patients. Deep vein thrombosis is a frequent complication of various surgical procedures. Knowing predisposing factors, including hereditary causes, and triggering risk factors will help us identify patients with high risk of venous thromboembolism. The prophylaxis recommendations by American College of Chest Physicians are made for groups of patients, for whom the benefits seem to outweigh the risks. However, those readers who want to adopt the American College of Chest Physicians' guidelines in their practices are urged to review in detail the pharmacology of the drugs used for thromboprophylaxis, relevant clinical studies, and case reports of spinal hematoma. Each patient might have different risks for thrombosis or bleeding and the potential for adverse consequences due to the prophylaxis. What is best for the group (the epidemiologic perspective) is not necessarily what is best for the individual patient (the clinical perspective).
- 1 July 2009
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 16 (4) , 300-303
Deep Vein Thrombosis Prophylaxis: Friend or Foe
This article reviews certain aspects of venous thromboembolism, a major cause of morbidity and mortality among hospitalized patients. Deep vein thrombosis is a frequent complication of various surgical procedures. Knowing predisposing factors, including hereditary causes, and triggering risk factors will help us identify patients with high risk of venous thromboembolism. The prophylaxis recommendations by American College of Chest Physicians are made for groups of patients, for whom the benefits seem to outweigh the risks. However, those readers who want to adopt the American College of Chest Physicians' guidelines in their practices are urged to review in detail the pharmacology of the drugs used for thromboprophylaxis, relevant clinical studies, and case reports of spinal hematoma. Each patient might have different risks for thrombosis or bleeding and the potential for adverse consequences due to the prophylaxis. What is best for the group (the epidemiologic perspective) is not necessarily what is best for the individual patient (the clinical perspective).